Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objectives of this study are as follows: • To determine the antiviral efficacy of LDV/SOF FDC as measured by the proportion of subjects who attain SVR at 12 weeks after discontinuation of therapy (SVR12) • To evaluate the safety and tolerability of each treatment regimen as assessed by review of the accumulated safety data
Inclusion criteria
- Chronic Genotype 1 and Genotype 4 Hepatitis C Virus Infection